Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Overview
- United States
- Healthcare Reform
- Funding New Healthcare Initiatives
- Pending Legislation
- Obstacles to Reform
- Pharmacy Benefi t Management Trends
- Recent Spending Trends
- Drug Pricing Trends
- Increasing Use of Generics
- Comparative Effectiveness Research
- Regulatory Pathway for Biosimilars
- Flexible Pricing Arrangements
- European Union
- Implications for EU of Court Ruling on Price Cuts and Freezes in Italy
- Court Ruling on Data Protection
- France
- Continued Steady Growth in the Generics Market
- Germany
- Market Trends
- Government Plans for Stricter Limits on Access to Some New Therapies
- Health Economic Evaluation
- New Restrictions on the Reimbursement of Certain Cardiometabolic Drugs
- Generics Substitution
- Italy
- Temporary Cuts in Pharmaceutical Spending
- Spain
- Legal Action Over Reimbursement Decisions
- Amendments to the Reference Pricing System
- Steady Growth of the Generics Market
- United Kingdom
- Flexible Pricing Arrangements
- Shifting Patterns of Parallel Trade
- Substantial Savings from the Use of Generics
- Japan
- Disagreement on Pricing Reform
- Continued Resistance to the Use of Generics
- First Biosimilar Approved in Japan
- Outlook and Implications for the Pharmaceutical Industry
Tables
- 1. Key Proposals for U.S. Healthcare Reform
- 2. Proposed Topics for U.S. Comparative Effectiveness Research of
Particular Relevance to the Pharmaceutical Industry
Figures
- 1. Leading PBMs' Growth Rates for Per Member Per Month Pharmaceutical
Expenditures, 2008
- 2. Leading PBMs' Reported Changes in Drug Prices, 2008
- 3. Leading PBMs' Generics Dispensing Rates, 2006-2008
- 4. Express Scripts' Calculations of Actual and Untapped Generics
Dispensing Rates and Potential Savings in the United States, 2008
- 5. Generics Dispensing Rates for Frequently Used Generics in France, 2008
- 6. Key Market Trends in Germany, 2008
- 7. Growth in German Statutory Health Insurance Expenditures on Drugs in
Select Therapeutic Areas, 2008
- 8. Generics' Share of the Spanish Pharmaceutical Market, 2000-2008
- 9. Impact of Generics on Spending on Select Drug Classes in England, 2008
|
Related Report
|
View Cart
